1-150806803-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000396.4(CTSK):c.3G>A(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000396.4 start_lost
Scores
Clinical Significance
Conservation
Publications
- pycnodysostosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Genomics England PanelApp, Ambry Genetics, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251234 AF XY:  0.00000736   show subpopulations 
GnomAD4 exome  AF:  0.00000889  AC: 13AN: 1461586Hom.:  0  Cov.: 32 AF XY:  0.00000825  AC XY: 6AN XY: 727100 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Pyknodysostosis    Pathogenic:3 
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
Variant summary: CTSK c.3G>A (p.Met1Ile) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. The next downstream in-frame start Met is located at codon 75. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251234 control chromosomes (gnomAD). c.3G>A has been reported in the literature in individuals affected with Pyknodysostosis (Arman_2014, Al-Araimi_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 35186389, 24767306, 33945887). ClinVar contains an entry for this variant (Variation ID: 551777). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided    Pathogenic:1 
This sequence change affects the initiator methionine of the CTSK mRNA. The next in-frame methionine is located at codon 75. This variant is present in population databases (rs778368118, gnomAD 0.003%). Disruption of the initiator codon has been observed in individual(s) with pycnodysostosis (PMID: 24767306). ClinVar contains an entry for this variant (Variation ID: 551777). This variant disrupts a region of the CTSK protein in which other variant(s) (p.Arg46Trp) have been determined to be pathogenic (PMID: 17206399, 24269275, 27092432). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at